Redefining the Standard of Care: The PROGRESS Trial Challenges the "Wait and See" Approach to Moderate Aortic Stenosis on November 3, 2026 Posted by
Decoding the Immune Stalemate: A New Frontier in Treating Chronic Diabetic Ulcers on November 3, 2026 Posted by
NewYork-Presbyterian and Spear Forge Landmark Partnership to Revolutionize Outpatient Rehabilitation Access Across NYC and Westchester on November 3, 2026 Posted by
Beyond the Salt Shaker: Why Potassium is the Missing Link in Global Heart Health on November 3, 2026 Posted by
Navigating the Future of Nutrition: A Comprehensive Review of the 2022-2023 Healthy Living Landscape on November 3, 2026 Posted by
Redefining the Standard of Care: The PROGRESS Trial Challenges the "Wait and See" Approach to Moderate Aortic Stenosis on November 3, 2026 Posted by
Decoding the Immune Stalemate: A New Frontier in Treating Chronic Diabetic Ulcers on November 3, 2026 Posted by
NewYork-Presbyterian and Spear Forge Landmark Partnership to Revolutionize Outpatient Rehabilitation Access Across NYC and Westchester on November 3, 2026 Posted by
Posted in Medical Innovations Viking Therapeutics Gains Momentum: Phase 2 Data Suggests Potential for Flexible Dosing in Obesity Treatment on September 23, 2026
Posted in Digital Health Tools Viking Therapeutics Shifts the Obesity Treatment Paradigm: Phase 2 Data Hints at Flexible Maintenance Dosing on September 22, 2026
Posted in Digital Health Tools Precision Medicine Surge: Electra Therapeutics Leads a Wave of Biotech Market Activity on September 20, 2026
Posted in Medical Innovations Strategic Pivot: Marea Therapeutics Secures Public Market Entry Through Lisata Acquisition on September 19, 2026
Posted in Digital Health Tools The Biotech Frontier: FDA Hiring Stalls, Neural Innovations, and the Future of Neuro-Therapeutics on September 18, 2026
Posted in Medical Innovations Biotech IPOs Surge: Electra Therapeutics Leads a Resurgent Market Toward 2021 Heights on September 18, 2026
Posted in Sleep Health Bridging Cardiology and Sleep Medicine: Vivos Therapeutics and South Palm Cardiovascular Associates Launch Regional Initiative on September 18, 2026
Posted in Medical Innovations Sling Therapeutics Secures $123 Million to Advance Oral Alternative for Thyroid Eye Disease on September 17, 2026
Posted in Digital Health Tools Biotech Pulse: Vera Therapeutics Targets Full Approval as Early-Stage Data Emerges Across the Sector on September 15, 2026
Posted in Digital Health Tools Breakthrough in IgA Nephropathy: Vera Therapeutics’ Trutakna Demonstrates Long-Term Clinical Efficacy on September 15, 2026
